Status:

COMPLETED

A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD

Lead Sponsor:

Astellas Pharma Inc

Conditions:

Prostate Cancer

Eligibility:

MALE

18-80 years

Phase:

PHASE3

Brief Summary

Phase IIIb, Open-label, randomized, controlled multi-centre study. Induction therapy phase for 6 months where all subjects receive 2 ELIGARD depot injections. Those subjects with hormone responsive pr...

Eligibility Criteria

Inclusion

  • At study entry (visit 1):
  • Written informed consent
  • Male subjects aged \>=18 and \<80 years old
  • Locally advanced (stage T3 or T4) prostate cancer or Relapsing prostate cancer following radical prostatectomy or,Relapsing prostate cancer following radiotherapy
  • Gleason score of \>=6
  • ECOG performance status of 0-2.
  • Life expectancy at least 5 years
  • At randomization (visit 4):
  • Two successive decreasing serum PSA levels \<=1 ng/ml

Exclusion

  • At study entry (visit 1):
  • Any suspected second primary tumors
  • Evidence of metastatic disease
  • Other malignancy within the last 5 years except
  • Acute spinal cord compression, uni- or bilateral ureteric obstruction
  • Any concurrent biological response modifier therapy
  • Concurrent chemotherapy
  • Less than 1 year since any prior neoadjuvant or adjuvant hormonal therapy
  • Less than 6 months since prior 5-alpha reductase inhibitor treatment
  • Other concurrent hormonal therapy
  • Any concurrent radiotherapy
  • Testosterone at screening \<= 1.7 mM or 50 ng/dL
  • Clinically significant elevation of serum creatinine or liver enzymes
  • Hypersensitivity to GnRH or other GnRH analogues or leuprorelin acetate
  • Hypersensitivity to CASODEXâ 50 mg.

Key Trial Info

Start Date :

March 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2012

Estimated Enrollment :

706 Patients enrolled

Trial Details

Trial ID

NCT00378690

Start Date

March 1 2006

End Date

December 1 2012

Last Update

June 4 2014

Active Locations (71)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 18 (71 locations)

1

Brussels, Belgium, 1070

2

Brussels, Belgium, 1200

3

Brussels, Belgium

4

Leuven, Belgium, B-3000